Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 10;12(6):761.
doi: 10.3390/brainsci12060761.

Repetitive Transcranial Magnetic Stimulation of the Primary Motor Cortex beyond Motor Rehabilitation: A Review of the Current Evidence

Affiliations
Review

Repetitive Transcranial Magnetic Stimulation of the Primary Motor Cortex beyond Motor Rehabilitation: A Review of the Current Evidence

Abdulhameed Tomeh et al. Brain Sci. .

Abstract

Transcranial magnetic stimulation (TMS) has emerged as a novel technique to stimulate the human brain through the scalp. Over the years, identifying the optimal brain region and stimulation parameters has been a subject of debate in the literature on therapeutic uses of repetitive TMS (rTMS). Nevertheless, the primary motor cortex (M1) has been a conventional target for rTMS to treat motor symptoms, such as hemiplegia and spasticity, as it controls the voluntary movement of the body. However, with an expanding knowledge base of the M1 cortical and subcortical connections, M1-rTMS has shown a therapeutic efficacy that goes beyond the conventional motor rehabilitation to involve pain, headache, fatigue, dysphagia, speech and voice impairments, sleep disorders, cognitive dysfunction, disorders of consciousness, anxiety, depression, and bladder dysfunction. In this review, we summarize the latest evidence on using M1-rTMS to treat non-motor symptoms of diverse etiologies and discuss the potential mechanistic rationale behind the management of each of these symptoms.

Keywords: non-motor symptoms; primary motor cortex; therapeutic use; transcranial magnetic stimulation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Graphical abstract summarizing the non-motor symptoms treated with M1-rTMS. ‡‡‡ denotes strong recommendation by current therapeutic guidelines, ‡‡ denotes moderate recommendation by current therapeutic guidelines, ‡ denotes weak recommendation by current therapeutic guidelines, * denotes supported by systematic reviews/meta-analyses. Figure created with BioRender.com (accessed on 19 November 2021).

Similar articles

Cited by

References

    1. Stinear C.M., Coxon J.P., Byblow W.D. Primary motor cortex and movement prevention: Where Stop meets Go. Neurosci. Biobehav. Rev. 2009;33:662–673. doi: 10.1016/j.neubiorev.2008.08.013. - DOI - PubMed
    1. Barker A.T., Jalinous R., Freeston I.L. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;1:1106–1107. doi: 10.1016/S0140-6736(85)92413-4. - DOI - PubMed
    1. Rossini P.M., Burke D., Chen R., Cohen L.G., Daskalakis Z., Di Iorio R., Di Lazzaro V., Ferreri F., Fitzgerald P.B., George M.S., et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin. Neurophysiol. 2015;126:1071–1107. doi: 10.1016/j.clinph.2015.02.001. - DOI - PMC - PubMed
    1. Pascual-Leone A., Valls-Solé J., Wassermann E.M., Hallett M. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain. 1994;117:847–858. doi: 10.1093/brain/117.4.847. - DOI - PubMed
    1. Chen R., Classen J., Gerloff C., Celnik P., Wassermann E.M., Hallett M., Cohen L.G. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology. 1997;48:1398–1403. doi: 10.1212/WNL.48.5.1398. - DOI - PubMed

LinkOut - more resources